Search
for
Sort by
Research 691–720 of 1000+
- The Dynamics of the Skin’s Immune System
- Severe Acute Respiratory Syndrome Among Children
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- DRUG‐ASSOCIATED ALOPECIA
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- An Overview of Alopecias
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- The Basic Science of Hair Biology
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review)
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Hair loss with levetiracetam in five patients with epilepsy
- Isoniazid-induced alopecia
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Disorders of hair
- In silico analysis of ethyl acetate Bruguiera gymnorhiza leaf extracts as an anti-inflammatory agent
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Atlas of Geriatric Dermatology
- Skin
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Janus Kinase inhibitors in dermatology: a review
- Cutaneous drug reactions
- Plakophilin 1 suppresses keratinocyte innate immune responses through DExD/H helicases
- Lipid nanocarriers as innovative strategies for hair regrowth
- Development of a Novel Mouse Model for Hair Regeneration Using Glue-like Adhesive Materials
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- sc-eQTL unveil immunogenetic architecture of polycystic ovary syndrome